Acute Heart Failure: Diagnosis and Management
Written by Dr. Muhammad Salar Raza · Manually reviewed by Dr. Muhammad Salar Raza · Content updated
Clinical Pathway
Acute heart failure presents with dyspnea, orthopnea, pulmonary crackles, elevated jugular venous pressure, and peripheral edema. Stabilize airway, breathing, and circulation first, give oxygen only if hypoxemic, and obtain an ECG, chest X-ray, BNP or NT-proBNP, and bedside echocardiogram. Patients with congestion and adequate blood pressure (warm and wet) receive intravenous loop diuretics such as furosemide, with vasodilators added if hypertensive. Hypoperfused patients (cold and wet) may need inotropes and urgent cardiology involvement. Always identify and treat the trigger: ischemia, arrhythmia, uncontrolled hypertension, infection, or non-adherence to medications.
Clinical Reasoning
BNP or NT-proBNP is the key discriminator when dyspnea could be pulmonary or cardiac; a normal value makes heart failure unlikely. The chest X-ray shows cardiomegaly, Kerley B lines, and bilateral effusions, while echocardiography defines ejection fraction and guides long-term therapy. A classic trap is the hypotensive patient: vasodilators and aggressive diuresis can worsen hypoperfusion, so blood pressure dictates the drug choice. Flash pulmonary edema with severe hypertension responds dramatically to vasodilators, whereas the same drugs are dangerous in aortic stenosis or right ventricular infarction.
Sample MCQ
A 65-year-old man presents with severe breathlessness, orthopnea, bilateral basal crackles, an S3 gallop, and a blood pressure of 170/100 mmHg. BNP is markedly elevated. What is the most appropriate initial management?
- AIntravenous furosemide
- BRapid intravenous fluid bolus
- COral amoxicillin for presumed pneumonia
- DImmediate endotracheal intubation
Correct Answer: Intravenous furosemide
The picture is acute decompensated heart failure with congestion and hypertension, so intravenous loop diuretics reduce preload and relieve pulmonary edema; vasodilators can be added because the pressure is high. A fluid bolus would worsen pulmonary congestion and is only appropriate in hypovolemic states, the opposite of this presentation. Amoxicillin treats pneumonia, but the S3 gallop, orthopnea, and elevated BNP point to heart failure rather than infection. Intubation is reserved for respiratory failure unresponsive to non-invasive support; most patients improve quickly with diuretics, positioning, and non-invasive ventilation if needed.
Guidelines and further reading
Related Clinical Topics
Acute Coronary Syndrome (ACS): Diagnosis and Emergency Management
Suspect ACS in any patient with prolonged ischemic chest pain, and obtain a 12-lead ECG within 10 minutes of arrival. Give chewable aspirin 162-325 mg and draw high-sensitivity troponin. ST-segment elevation (STEMI) requires immediate reperfusion: primary PCI within 90 minutes of first medical contact, or fibrinolysis within 30 minutes if timely PCI is unavailable. NSTEMI and unstable angina are managed with dual antiplatelet therapy, anticoagulation, high-intensity statin, and risk-stratified invasive evaluation. Treat pain with nitrates if no contraindication, control blood pressure and heart rate with a beta blocker once stable, and screen for complications such as arrhythmia and acute heart failure.
Stable Angina Pectoris: Clinical Evaluation
Stable angina is characterized by episodic chest discomfort that is predictably provoked by exertion or emotional stress and relieved by rest or nitroglycerin. The initial evaluation involves a thorough history and physical examination, followed by a resting ECG. If the patient can exercise and has a normal resting ECG, an exercise stress test (treadmill ECG) is the preferred initial non-invasive functional test for diagnosing ischemic heart disease. Patients with abnormal resting ECGs or inability to exercise require imaging-based stress testing (e.g., stress echocardiography or nuclear perfusion imaging).
Heart Failure with Reduced Ejection Fraction: Diagnosis and Management
Heart Failure with Reduced Ejection Fraction (HFrEF) is a clinical syndrome characterized by the heart's inability to pump sufficient blood to meet the body's metabolic demands due to impaired systolic function of the left ventricle, typically defined by a left ventricular ejection fraction (LVEF) of 40% or less. Treatment for HFrEF focuses on guideline-directed medical therapy (GDMT) including angiotensin receptor-neprilysin inhibitors (ARNI), beta-blockers, mineralocorticoid receptor antagonists (MRA), and sodium-glucose cotransporter-2 (SGLT2) inhibitors to reduce mortality and morbidity. Diuretics are used for symptom relief from congestion, and device therapies like implantable cardioverter-defibrillators (ICD) or cardiac resynchronization therapy (CRT) may be indicated for selected patients. Lifestyle modifications, such as dietary sodium restriction and fluid management, are also crucial. Patients commonly present with progressive exertional dyspnea, orthopnea, paroxysmal nocturnal dyspnea, and fatigue due to reduced forward flow. Physical signs may include peripheral edema, jugular venous distension, pulmonary rales (crackles), an S3 gallop, and hepatomegaly, indicating fluid congestion.
SMLE Preparation Resources
Master the 2026 SMLE
Explore more clinical protocols in the SMLEREVISE Clinical Knowledge Library.
Try the QBank & Scaled Mocks